My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
AG 2017 12 18
CabarrusCountyDocuments
>
Public Meetings
>
Agendas
>
BOC
>
2017
>
AG 2017 12 18
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/20/2019 6:11:04 PM
Creation date
3/20/2019 5:20:10 PM
Metadata
Fields
Template:
Meeting Minutes
Doc Type
Agenda
Meeting Minutes - Date
12/18/2017
Board
Board of Commissioners
Meeting Type
Regular
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
320
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
c) are not presently indicted for or otherwise criminally or civilly charged by a governmental entity <br />(federal, State, or local) with commission of any of the offenses enumerated in paragraph 2. (A) (b) <br />of this certification. <br />d) Have not within a three-year period preceding this application had one or more public transaction <br />(federal, State, or local) terminated for cause or default. <br />B. Where the applicant is unable to certify to any of the statements in this certification, he or she shall <br />attach an explanation to this certification. <br />3. DRUG-FREE WORKPLACE (GRANTEES OTHER THAN INDIVIDUALS) <br />As required by the Drug -Free Workplace Act of 1988, and implemented at 7 CFR Part 3021, Subparts A, <br />B, and E, for grantees, as defined at 7 CFR Part 3021: <br />A. The applicant certifies that it will or will continue to provide a drug-free workplace by: <br />a) Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, <br />possession, or use of a controlled substance is prohibited in the grantee's workplace and <br />specifying the actions that will be taken against employees for violation of such prohibition; <br />b) establishing an on-going drug-free awareness program to inform employees about: <br />i. The dangers of drug abuse in the workplace; <br />ii. The grantee's policy of maintaining a drug-free workplace; <br />iii. Any available drug counseling, rehabilitation, and employee assistance programs; and <br />iv. The penalties that may be imposed upon employees for drug abuse violations occurring in the <br />workplace; <br />c) making it a requirement that each employee to be engaged in the performance of the <br />grant be given a copy of the statement required by paragraph (a); <br />d) notifying the employee in the statement required by paragraph (a) that, as a condition of <br />employment under the grant, the employee will: <br />i. Abide by the terms of the statement; and <br />ii. Notify the employer in writing of his or her conviction for a violation of a criminal <br />drug statute occurring in the workplace no later than five calendar days after such <br />conviction; <br />e) notifying the agency, in writing, within 10 calendar days after receiving notice under <br />subparagraph (d)(ii) from an employee or otherwise receiving actual notice of such <br />conviction. <br />Notice shall include the identification number(s) of each affected grant; <br />f) taking one of the following actions, within 30 calendar days of receiving notice under <br />subparagraph (d)(ii), with respect to any employee who is so convicted: <br />i. Taking appropriate personnel action against such an employee, up to and <br />including termination, consistent with the requirements of the Rehabilitation Act of <br />1973 (29 U.S.C. 794), as amended; or <br />ii. requiring such employee to participate satisfactorily in a drug abuse assistance or <br />rehabilitation program approved for such purposes by a federal, State, or local <br />health, law enforcement, or other appropriate agency; <br />g) making a good faith effort to continue to maintain a drug-free workplace through <br />implementation of paragraphs (a), (b), (c), (d), (e), and (f). <br />Attachment number 2 \n <br />NCDA&CS Certifications & Assurances Page 2 of 3 <br />Rev 7114 F-10 Page 263 <br />
The URL can be used to link to this page
Your browser does not support the video tag.